| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/13/2002 | CN1339460A New polypeptide-human severing stimulating factor 50 kda subunit 86.35 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339459A New polypeptide-nodule TGF-beta-similar protein 33.44 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339458A New polypeptide-nuclear factor kappa-B DNA binding subunit 10.23 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339457A New polypeptide-chloride channel protein 17.6 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339455A New polypeptide-eukaryotic initiation factor (eIF)-4C31.68 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339454A New polypeptide-ribosomal protein L312.54 and polynucleotide for encoding said polypeptide |
| 03/13/2002 | CN1339453A New polypeptide-double strand RNA joint zinc finger protein 25.19 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339452A New polypeptide-pescadillo protein 11.55 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339451A New polypeptide-Alu factor relative P97 protein 44.66 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339450A New polypeptide-transposition primer protein 14.41 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339449A New polypeptide-70 KD U1-sn RNP splicing factor relative protein 58.74 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339448A New polypeptide-transcription regulation protein 34.54 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339447A New polypeptide-proteasome subunit nu 47.52 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339446A New polypeptide-conjugative factor SF 110.34 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339445A New polypeptide-Alu factor relative p97 protein 32.34 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339444A New polypeptide-glutamic acid receptor-interaction protein 1-75.46 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339319A Medicine for treating AIDS and its preparing method |
| 03/13/2002 | CN1339318A Method for treating AIDS and its preparing method |
| 03/12/2002 | USRE37582 Cytokine designated LERK-6 |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355803 Compound comprising extended, coplanar, conjugated system, formed by attachment of functional group comprising aromatic ring and electron-donating group on acridinium nucleus, which maintains coplanarity during light emission |
| 03/12/2002 | US6355780 Death domain modulators; tumor and cancer therapy; therapy for eating disorders, hepatitis, inflammatory disease, liver disorders and rheumatic diseases |
| 03/12/2002 | US6355484 Methods and compositions for polypeptides engineering |
| 03/12/2002 | US6355481 Hybridoma cell line and monoclonal antibody for huntingtin protein |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
| 03/12/2002 | US6355442 Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 03/12/2002 | US6355440 Detecting cell growth factors in sample; mix target sample with preferential receptors, detect binding, bound receptor indicates presence of cell growth factor in sample |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355253 Bactericidal antibodies |
| 03/12/2002 | US6355247 Nucleic acid immunization using a virus-based infection/transfection system |
| 03/12/2002 | US6355245 Glomerulonephritis,antibodies at low dosage |
| 03/12/2002 | US6355244 Methods and compositions for the treatment of psoriasis |
| 03/12/2002 | US6355235 Topical application of antibodies for contraception and for prophylaxis against sexually transmitted diseases |
| 03/12/2002 | CA2189657C Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/12/2002 | CA2034741C Therapeutic antibody based fusion proteins |
| 03/12/2002 | CA1341347C Androgen receptor proteins, recombinant dna molecules coding for such, and use of such compositions |
| 03/08/2002 | CA2358061A1 Novel antibody compositions for the negative selection of specific rat leukocyte subsets |
| 03/07/2002 | WO2002018954A2 Inhibition of cmv infection and dissemination |
| 03/07/2002 | WO2002018948A2 Differentially expressed epitopes and uses thereof |
| 03/07/2002 | WO2002018633A2 Determination of the ability of patients to respond to tumour treatment |
| 03/07/2002 | WO2002018620A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | WO2002018603A1 Isomaltulose synthase |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018581A2 G-protein coupled receptors |
| 03/07/2002 | WO2002018576A2 Compositions and methods relating to lung specific genes |
| 03/07/2002 | WO2002018575A2 Genes expressed in the cell cycle |
| 03/07/2002 | WO2002018565A2 Regulation of human protein phosphatase iic-like enzyme |
| 03/07/2002 | WO2002018562A1 Airway-specific trypsin-like enzymes and method of using the same |
| 03/07/2002 | WO2002018557A2 Human kinases |
| 03/07/2002 | WO2002018554A2 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 03/07/2002 | WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | WO2002018536A2 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 03/07/2002 | WO2002018446A2 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| 03/07/2002 | WO2002018445A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | WO2002018444A2 Erbb4 antagonists |
| 03/07/2002 | WO2002018443A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | WO2002018442A1 Stabilisation of immunoglobulins at a low ph |
| 03/07/2002 | WO2002018422A1 Amino acid substitution mutants of interleukin 13 |
| 03/07/2002 | WO2002018418A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2002017899A2 Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| 03/07/2002 | WO2002017857A2 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | WO2002000005A8 Libraries displaying human antibody fragments with hybrid complementarity determining regions |
| 03/07/2002 | WO2001094420B1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 03/07/2002 | WO2001087233A3 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof |
| 03/07/2002 | WO2001085777A3 Therapeutic pore-forming peptides |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001077181A3 Anti-rhesus d monoclonal antibodies |
| 03/07/2002 | WO2001072330A3 Method for immunostimulation using binding agents for the fc rec eptor of immunoglobulin a and for cancer cells or infections antigen |
| 03/07/2002 | WO2001068122A3 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 03/07/2002 | WO2001064872A3 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001057233A3 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001044808A3 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/07/2002 | WO2001042285A3 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001038360A3 Novel hcv non-structural polypeptide |
| 03/07/2002 | WO2001037873A3 Method and system to remove cytokine inhibitor in patients |
| 03/07/2002 | WO2001032888A3 Human transferase molecules |
| 03/07/2002 | WO2001031008A3 Human and rat fgf-20 genes and gene expression products |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2001029218A3 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 03/07/2002 | WO2001021654A3 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/07/2002 | WO2001011086A3 Methods of screening for angiogenesis modulators |
| 03/07/2002 | WO2001011049A3 Methods and compositions concerning canine interleukin 5 |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | WO2000056352A3 Reagents and methods useful for detecting diseases of the prostate |
| 03/07/2002 | US20020029395 Flowering locus T (FT) and genetically modified plants having delayed flower development |
| 03/07/2002 | US20020029391 Epitope-driven human antibody production and gene expression profiling |
| 03/07/2002 | US20020028917 Separation of avian antibodies |
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028495 Deoxyribonuclease II beta proteins and cDNAs |
| 03/07/2002 | US20020028488 Transgenic avian species for making human and chimeric antibodies |